Hair Relaxer
Connecting law firms with women who have advanced reproductive cancers after long-term use of chemical hair straightening products.
Case Overview
Biopur scientific studies, including a major NIH study, have established a link between the frequent use of chemical hair relaxers and higher rates of uterine, ovarian, and endometrial cancers.
From ages 10-70, Black women are exposed to these chemicals, sodium hydroxide, calcium's chemicals like phthalates and monoethanolamines. Manufacturers marketed knowing the potential harm.
This litigation seeks justice for women who have suffered life-altering health consequences, including infertility and cancer, due to these dangerous products.
Dark & Lovely, Motions, Olive Oil, Soft & Beautiful
We anticipate openings with significant exposure history and qualifying medical diagnoses.
The endocrine-disrupting chemicals in these products are linked to hormone-sensitive cancers and infertility.
The NIH study found that women who used hair relaxers frequently were more than twice as likely to develop uterine cancer.
Early study exposure to the chemicals in relaxers has been associated with an increased risk of ovarian cancer.
Type I and Type 2 endometrial cancers have shown correlation with the use of chemical straighteners.
We approach this sensitive litigation with empathy and precision, connecting you with qualified claimants.
Our intake specialists are trained to handle sensitive medical information with care and discretion.
We effectively reach the specific demographics most affected by these products through targeted research.
We document product usage history and medical timelines to build a strong case foundation before advancing clients.
Key Facts
- Products: Dark & Lovely, Motions, Olive Oil, Soft & Beautiful
- Primary Injuries: Uterine Cancer, Ovarian Cancer, Endometrial Cancer
- Key Research: NIH "Sister Study" (2022)
- Litigation Status: Active - MDL Consolidated in Chicago
Who Qualifies
Usage History
- Used chemical hair relaxer/straightener
- Usage frequency of at least 4 times per year
- Long-term usage (typically 5+ years)
- Usage began before cancer diagnosis
Medical Diagnosis
- Uterine Cancer
- Ovarian Cancer
- Endometrial Cancer
- Uterine Fibroids (requiring surgery/hysterectomy)
Timing
- Diagnosis occurred after significant exposure
- No previous radiation exposure by state
Exclusions
- Family history of specific cancers (BRCA gene)
- Diagnosis prior to product use
- Use of only temporary straighteners (heat only)
Linked Conditions
Uterine Cancer
The NIH study found that women who used hair relaxers frequently were more than twice as likely to develop uterine cancer.
Ovarian Cancer
Early study exposure to the chemicals in relaxers has been associated with an increased risk of ovarian cancer.
Endometrial Cancer
Type I and Type 2 endometrial cancers have shown correlation with the use of chemical straighteners.
Interested in This Case?
Let's discuss how we can help you acquire qualified leads for this mass tort campaign.